FDA Investigator Robert J Doyle
Robert J Doyle has conducted inspections on 11 sites in 5 countries as of 08 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
08 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Germany,
Switzerland,
United States of America,
Israel,
India
FDA Investigators that have inspected at least one site in common with Robert J Doyle:
Anastasia M Shields,
Andrew Le,
Angela E Glenn,
Arsen Karapetyan,
Azza Talaat,
Bapu R Gaddam,
Barbara M Frazier,
Chaoying C Ma,
Charisse K Green,
Charles D Brown,
Cheryl A Clausen,
Courtney N Long,
Dandan Wang, PhD,
Daniel J Grabicki,
Daniel J Lahar,
Darren S Brown,
David J Gomes,
Demitria J Xiradakis,
Dipesh K Shah,
Dr. Barbara D Paul, PhD,
Dr. Carmelo Rosa,
Emily J Orban,
Erika V Butler,
Farhana Khan,
Gam S Zamil,
Gavin T Cua,
Grace E Mcnally,
Helen Verdel,
Iraida Ortiz,
Jacob G Lutz,
James L Dunnie, Jr,
James W Leonette,
Jennifer C Adams,
Joey V Quitania,
Jose A Lopez,
Jose R Hernandez,
Junho Pak,
Karen S Anthony,
Katherine Szestypalow,
Kenneth M Gordon,
Kevin A Gonzalez,
Kham Phommachanh,
Larry K Austin,
Lata C Mathew, PhD,
Laurimer Kuilan Torres,
LCDR Anastasia M Piliafas Brown,
Lori J Silverstein,
Lori S Lawless,
Luis Mburgos Medero,
Lydia I Rosas Marty,
Maan S Abduldayem,
Makini Cobourne Duval, PhD,
Margaret M Annes,
Marie F Morin,
Matthew B Casale,
Meisha R Sampson,
Meisha Waters,
Meyer J Slobotsky,
Michael A Charles,
Michael A Taylor,
Michael S Araneta,
Michele L Obert,
Mohsen Rajabi Abhari, FDA,
Muralidhara B Gavini, PhD,
Nicole E Knowlton,
Noreen Muñiz,
Norman K Starks,
Paraluman S Leonin,
Parul M Patel,
Paul L Bellamy,
Peter R Lenahan,
Pratik S Upadhyay, DDC,
Raymond T Oji,
Rita K Kabaso,
Rochelle K Kimmel,
Ronald T Nowalk,
Ruben C Ayala, PharmD,
S Lori Brown, PhD MPH,
Saied A Asbagh,
Sam H Haidar, PhD,
Sangeeta M Khurana, PhD,
Satheesh Thomas,
Sean R Marcsisin,
Sharon K Thoma, PharmD,
Stacey S Degarmo,
Stephen D Brown,
Steven J Thurber,
Steven M Weinman,
Steven P Donald,
Ted L Anderson,
Thomas J Arista,
Unnee Ranjan,
Vilmary Negron Rodriguez,
Viviana Matta,
Yumi J Hiramine,
Zachary A Bogorad,
Zachary L Miller
Robert J Doyle's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2003 | FDA 483 Response | Padagis Israel Pharmaceuticals Ltd - Form 483R, 2003-09-15 |
September, 2003 | FDA 483 | Padagis Israel Pharmaceuticals Ltd - Form 483, 2003-09-04 |
August, 2003 | EIR | Teva Pharmaceutical Industries Ltd. - EIR, 2003-10-24 |
April, 2004 | EIR | Apitoria Pharma Private Limited - EIR, 2004-06-14 |
April, 2001 | FDA 483 | Riverain Medical Group - Form 483, 2001-04-09 |
September, 2003 | EIR | Padagis Israel Pharmaceuticals Ltd - EIR, 2003-10-24 |
August, 2003 | FDA 483 | Teva Pharmaceutical Industries Ltd. - Form 483, 2003-08-28 |
August, 2003 | FDA 483 Response | Teva Pharmaceutical Industries Ltd. - Form 483R, 2003-08-28 |
September, 2003 | FDA 483 | WAVELENGTH ENTERPRISES LTD - Form 483, 2003-09-10 |
September, 2003 | FDA 483 Response | WAVELENGTH ENTERPRISES LTD - Form 483R, 2003-11-09 |
September, 2003 | EIR | WAVELENGTH ENTERPRISES LTD - EIR, 2003-10-24 |
April, 2001 | EIR | Riverain Medical Group - EIR, 2001-04-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more